A strategy to combine pathway-targeted low toxicity drugs in ovarian cancer.

Delaney JR, Patel C, McCabe KE, Lu D, Davis MA, Tancioni I, von Schalscha T, Bartakova A, Haft C, Schlaepfer DD, Stupack DG
Oncotarget. 2015 Oct 13;6(31):31104-18. doi: 10.18632/oncotarget.5093. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.